H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Census population 429,954. Minnesota Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Minneapolis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Minneapolis storefront.
Tendon and Ligament Support Therapy in Minneapolis, MN for clinics & physicians. Biologic therapies for te… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. 9.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick tendon ligament support therapy against that mix.
National Tendon and Ligament Support Therapy notes (how the product actually works)J6 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Minneapolis is 7.4% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Minneapolis warehouse or a five-star local review. What you get is tendon ligament support therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J6, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 7.4% of adults — 4.6 points below the U.S. 12% figure. Obesity is 28.6%; arthritis is 15.2%. That is place-level BRFSS modeling, not a clinic census and not a Minneapolis trial.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow National Government Services (NGS) CTP articles. Mixing those codes is a billing error.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Minneapolis.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Minnesota.
If you operate in Minnesota and another MAC state, say it on the first call. J6 will not port 1:1. We would rather split utilization than watch a sister clinic copy Minneapolis tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Minneapolis, MN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Minneapolis is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Minneapolis — 4.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Minnesota Part B wound biologics follow this contractor (siblings: IL, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Minneapolis. Useful for joint-program math; still needs a diagnosis and privileging.
No Minneapolis storefront. Joe Bradley is an active practice owner. tendon ligament support therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.